osimertinib
astrazeneca
['adaura', 'osimertinib', 'aura ,(-laura)']
please check out this cost effectiveness analysis done by and i based on various projected final adaura os results. we calculated that adjuvant osimertinib would be cost effective if the os benefit was 0.7 hr or lower, so 0.49 exceeds this. #asco23 
Professor and thoracic oncologist, Vice Chair Clinical Research @ClevelandClinic TCI, @ASCO #EdBook Editor in Chief, Dad, Steelers fan. All opinions mine. #LCSM